Is Pharma back on growth track? Here's why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma
Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.
Source: businesstoday.in
Stay updated with breaking news from Diazepem Gel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.